
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
Novartis is named among the 2014 Corporate Knights Global 100.
In addition, Novartis has also been listed in the STOXX Global ESG Leaders Index, recognized among the 25 best multinational employers by Great Place to Work Institute, and ranked top pharmaceutical company in Fortune's World's Most Admired Companies.
Source:





